您的位置: 首页 > 农业专利 > 详情页

METHODES DE TRAITEMENT DU CANCER AU MOYEN D'UNE COMBINAISON D'UN AGENT A BASE DE PLATINE ET D'UN CONJUGUE ANTICORPS ANTI-FACTEUR TISSULAIRE-MEDICAMENT
专利权人:
GENMAB A/S
发明人:
RANGWALA, RESHMA ABDULLA,BREIJ, ESTHER C. W.,VERPLOEGEN, SANDRA,ABIDOYE, OYEWALE O.,NICACIO, LEONARDO VIANA
申请号:
CA3091821
公开号:
CA3091821A1
申请日:
2019.03.20
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
The invention provides a platinum-based agent (e.g., carboplatin) in combination with an antibody-drug conjugate that binds to tissue factor (TF) (e.g., tisotumab vedotin) and their use in methods of treating cancer, such as bladder cancer and cervical cancer. The invention also provides compositions and kits comprising the platinum-based agent (e.g., carboplatin) and the antibody-drug conjugate that binds to TF (e.g., tisotumab vedotin) for use in treating cancer, such as bladder cancer and cervical cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充